After years of clinical suspicion, large studies confirm elevated risk across multiple cancers From Lewis S Blevins Jr., MD – Professor of Neurological Surgery, Medical Director of the California Center for Pituitary Disorders at UCSF
Dr. Blevins Corner
Medical comments from Dr. Lewis Blevins MD. Director Center for Pituitary Disorders at University California San Francisco
The remarkable case of a giant pituitary adenoma
February 25, 2022
From the University of California, San Francisco, (UCSF) MedConnection comes a fascinating article about a patient with a giant pituitary adenoma removed via endoscopic endonasal surgery.
A case of a pituitary lesion (hemangiopericytoma)
February 21, 2022
In this podcast oriented to physicians, Dr. Lewis Blevins talks about a case of a patient with a pituitary lesion called a hemangiopericytoma invasive in the right cavernous sinus. Although the content is technical, patients and other interested parties may find the discussion interesting.
A review of six drugs to treat hypercortisolism
February 17, 2022
Here are links to Dr. Blevins’ discussion of five drugs to treat hypercortisolism.
Medications for Cushing’s disease: a review.
December 1, 2021
We are pleased to announce a series of podcasts on the medical management of hypercortisolism.
Pituitary tumors are not brain tumors.
September 30, 2021
Learn why pituitary tumors are not brain tumors—and why that distinction matters for diagnosis and treatment.
Webinar: The complexities of hormone levels and symptoms of pituitary conditions
August 5, 2021
Two outstanding informational webinars were made available to Pituitary World News by Dr. Lewis Blevins, co-founder and medical director of the California Center for Pituitary Disorders at UCSF Medical Center. These webinars are designed primarily
Hypercortisolism Emerging Clinical Insights
June 7, 2021
A presentation from Lewis Blevins, M.D. Pituitary World News cofounder and Medical Director of the California Center for Pituitary Disorders at UCSF on the emerging clinical insights of hypercortisolism. Click here to view the presentation.
News from the California Center for Pituitary Disorders at UCSF
January 25, 2021
From our friends at UCSF: Read this great update with links to articles on telemedicine for patients with pituitary disorders, making surgery safer during the Covid-19 pandemic, common mistakes made when treating patients with central hypothyroidism,
Follow ups: Why are they so critical?
January 18, 2021
Two cases where patients’ lack of follow-up leads to complications that likely could have been avoided.
Inquiries
January 14, 2021
Interesting inquiries prompted by the questions patients leave in their health portals.
A pituitary patient’s experience with COVID-19
January 7, 2021
A compelling, detailed account of a pituitary patient’s experience with COVID-19 everyone should listen. As the virus takes hold in what is undoubtedly the worst phase of this pandemic, we urge you to follow all
Telemedicine and COVID-19, insights from our survey
December 28, 2020
Not surprisingly, COVID-19 appears to have significantly impacted pituitary patients’ access to healthcare. Our brief survey elicited information from respondents on their experiences and attitudes towards obtaining healthcare via telemedicine. Dr. Blevins shares the findings